Addex Therapeutics (ADXN) Other financing activities (2023 - 2024)
Addex Therapeutics' (ADXN) quarterly Other financing activities came in at $6.7 billion in Q3 2024, up 100.35% year-on-year from $3.4 billion in Q4 2023, and up 100.35% quarter-over-quarter from -$1922.9 billion in Q3 2023.
Addex Therapeutics (ADXN) Other financing activities (2023 - 2024) Analysis & Trends
Addex Therapeutics has disclosed Other financing activities across 2 years of filings, most recently posting $6.7 billion for Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Addex Therapeutics | 1.08 Bn | 1.08 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 6.73 Bn |
| Sep 30, 2024 | 6.73 Bn |
| Sep 30, 2023 | -1,922.90 Bn |
| Sep 30, 2023 | -1,922.90 Bn |